Potent Activity of an Anti-ICAM1 Antibody-Drug Conjugate against Multiple Myeloma.

Daniel W SherbenouYang SuChristopher R BehrensBlake T AftabOlivia Perez de AchaMegan MurnaneShelby C BearrowsByron C HannJeffery L WolfThomas G MartinBin Liu

Published in: Clinical cancer research : an official journal of the American Association for Cancer Research (2020)

We propose that anti-ICAM1 ADC should be further studied for toxicity, and if safe, tested for clinical efficacy in patients with relapsed or refractory multiple myeloma.

Keyphrases

multiple myeloma
oxidative stress
diffusion weighted imaging
diffusion weighted
acute lymphoblastic leukemia
computed tomography
magnetic resonance
magnetic resonance imaging
diffuse large b cell lymphoma